Sponsor or institution
Clinical trials and research at Guangzhou Institute of Respiratory Disease
As of November 12, 2026, Find a Trial lists 9 clinical trials run by Guangzhou Institute of Respiratory Disease that are recruiting, in China. By phase: Phase 2 (2), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1Country
Newest trials
All recruiting trials (9)
-
OSA Screening in Diverse Populations
This study tests how common obstructive sleep apnea is across community members and people with certain diseases in China, using screening questionnaires and polysomnography or portable sleep monitors.
-
ADC Mechanisms in HER2/TROP2 NSCLC Using Patient-Derived Organoids
This study tests how antibody-drug conjugates work in HER2- or TROP2-positive non-small cell lung cancer using organoid models made from patient tumors.
-
NMR blood test to detect checkpoint inhibitor–related pneumonitis in people with lung cancer
This project will test whether a blood 1H‑NMR lipoprotein and metabolite profile can help detect pneumonitis caused by immune checkpoint drugs earlier in people with lung cancer.
-
Exploring genetic factors in childhood asthma
This study is trying to see if certain genetic factors are linked to asthma in children to help find better treatments and prevention methods.
-
Evaluating a combination treatment for advanced lung cancer and COPD
This study is testing a new combination treatment for people with advanced lung cancer and COPD to see if it helps them feel better and manage both conditions more effectively.
-
Combining irinotecan liposome or etoposide with adebrelimab and carboplatin for extensive stage small cell lung cancer
This study is testing two different treatment combinations to see if they can help people with extensive stage small cell lung cancer live longer and feel better.
-
Injection of toluenesulfonamide for advanced lung cancer treatment
This study is testing if injections of a new treatment called toluenesulfonamide can help people with advanced lung cancer feel better and live longer, either on its own or alongside standard chemotherapy and immunotherapy.
-
Cryoablation combined with Karelizumab and Apatinib for lung cancer treatment
This study is testing whether using cryoablation together with Karelizumab and Apatinib can safely help people with multiple primary lung cancers that lack known driver genes.
-
Maintenance lurbinectedin with serplulimab after first-line therapy for extensive-stage small cell lung cancer
This study tests whether continuing lurbinectedin with serplulimab after initial treatment helps people with extensive-stage small cell lung cancer stay disease control.
Quick answers
How many clinical trials run by Guangzhou Institute of Respiratory Disease are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.